Search

Your search keyword '"Syrigos KN"' showing total 346 results

Search Constraints

Start Over You searched for: Author "Syrigos KN" Remove constraint Author: "Syrigos KN"
346 results on '"Syrigos KN"'

Search Results

1. Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors

2. The clinical significance of molecular markers to bladder cancer

3. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): A multicentre, double-blind, randomised phase 3 trial

4. Clinical significance of heat shock protein-70 expression in bladder cancer

5. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients

6. Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis

7. Circulating VEGF levels in the serum of gastric cancer patients - Correlation with pathological variables, patient survival, and tumor surgery

8. Serum E-cadherin concentrations and their response during laparoscopic and open cholecystectomy

9. Clinical significance of serum and urinary c-erbB-2 levels in colorectal cancer

10. Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery

12. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery

13. The development of monoclonal antibody therapy in leukemias

14. Beta human chorionic gonadotropin concentrations in serum of patients with pancreatic adenocarcinoma

15. Autoantibodies against cardiolipin in the serum of patients with colorectal adenocarcinoma: Their prognostic significance

16. Autoantibodies in the serum of patients with gastric cancer: Their prognostic importance

17. The effect of vertical banded gastroplasty on glucose-induced beta-endorphin response

18. Thyroid autoantibodies and thyroid function in patients with pancreatic adenocarcinoma

19. Sex hormone levels in the serum of patients with pancreatic adenocarcinoma

20. Autoantibodies against insulin and beta-islet cells in pancreatic adenocarcinoma: A possible explanation for diabetes mellitus

21. EFFECT OF TESTOSTERONE ADMINISTRATION, PRENATALLY AND POSTNATALLY, ON THE IMMUNE-SYSTEM OF RATS

22. THYROID AUTOANTIBODIES AND THYROID-FUNCTION IN PATIENTS WITH GASTRIC-CANCER

26. A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer.

27. Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients.

29. Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.

31. Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study.

32. Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the host.

33. Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy.

34. Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: A literature review.

35. Protection conferred by booster vaccine doses in hospitalized patients with COVID-19 during the SARS-CoV-2 Omicron BA.2 and BA.5 epidemics from 2022 to 2023 in Greece.

36. Molecular Diagnostics and Treatment Patterns in Metastatic Non-small Cell Lung Cancer Patients: Real World Evidence from Greece: LACHESIS Study.

37. Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation.

38. Robotic Bronchoscopy in Lung Cancer Diagnosis.

39. Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets.

40. The Gap of Health Inequalities Amongst Lung Cancer Patients of Different Socioeconomic Status: A Brief Reference to the Greek Reality.

41. Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study.

42. Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases.

43. Efficacy of Tocilizumab in Severely Ill COVID-19 Patients With Rapid Respiratory Deterioration: A Single Center Experience During the Third Pandemic Wave in Greece.

44. Clinical Outcomes Beyond 1L EGFR -TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.

45. Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece.

46. Evolving Treatment Landscape of HER2 -mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond.

47. Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.

48. Prolonged SARS -CoV-2 Infection With Common Features in Two Patients Receiving Anti-CD20 Therapy.

49. Baseline gene expression profiling determines long-term benefit to programmed cell death protein 1 axis blockade.

50. Noncoding RNA-mediated regulation of pyroptotic cell death in cancer.

Catalog

Books, media, physical & digital resources